Proof of Very Low Acute/Chronic Toxicity of Postoperative (Breast-conserving Surgery) APBI by Interstitial Multicatheter High-Dose-Rate Brachytherapy for Early Breast Cancer (BC) - One-Year Outcomes of a Prospective Assessment Study in 77 Patients
The composite therapy concept consisting of breast-conserving surgery (BCS) followed by whole-breast irradiation (WBI) is an appropriate and established therapy for UICC (Union International Cancer Centre) Stage I and II breast cancer (BC) according to several mature randomized trials: Protocol B-06, the Milan trial, and EORTC 10801 trial. In addition, the recently published randomized GEC-ESTRO trial demonstrated equivalence between the established WBI and the concept of accelerated partial breast irradiation (APBI) by interstitial multicatheter brachytherapy (mBT) in low-risk early breast cancer.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Razvan M. Galalae, Rodrigo Hepp, Rebecca Galalae, Katja Polz, Lisa Nielinger, Jan-Philipp Exner, Georg Schabl, Abdallah Abdallah Source Type: research
More News: Brachytherapy | Breast Cancer | Breast Conservation Surgery | Cancer | Cancer & Oncology | Study | Toxicology